Truist lowered the firm’s price target on CVS Health to $103 from $109 and keeps a Buy rating on the shares as part of a broader research note on Healthcare Services names. The analyst cites the recent market moves and updates in multiples following commentary from both UnitedHealth (UNH) and Humana (HUM) around an uptick in utilization, reducing targets in Managed Care and bumping Hospital targets while remaining “broadly bullish” on both groups.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on CVS:
- Wells Fargo Sees Potential Purchase Window in Managed Care Stocks
- UNH Slide Prompts a Catastrophe for Health Insurer Stocks
- CVS Health announces 18 megawatt agreement with Constellation
- UnitedHealth slides, drags peers on warning of higher medical costs
- Agilon Health initiated with an In Line at Evercore ISI